Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06885281 · ClinicalTrials.gov registry record · Phase 1

A Study of ZL-1310 in Participants With Selected Solid Tumors

A Phase 1 study of Solid Tumors, sponsored by Zai Lab (Shanghai) Co..

Recruiting
Registry status
Phase 1
Development phase
112
Enrollment target
16
Study locations

NCT06885281 is a Phase 1 study of Solid Tumors that is actively recruiting participants, run by Zai Lab (Shanghai) Co.. The registered enrollment target is 112 participants, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (61% lower). The trial reports 16 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06885281, a Phase 1 study of Solid Tumors, is actively recruiting participants, sponsored by Zai Lab (Shanghai) Co..

RECRUITING
Registry status
Phase 1
Development phase
112 participants
Enrollment target
16
Study locations

Study Summary

A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

Conditions Studied

Solid Tumors

Interventions

  • DRUG ZL-1310

Study Locations (16)

Texas

  • Zai Lab Site 2003 - Dallas
  • Zai Lab Site 2007 - Houston

Beijing Municipality

  • Zai Lab Site 1002 - Beijing
  • Zai Lab Site 1013 - Beijing

Guangdong

  • Zai Lab Site 1016 - Guangzhou
  • Zai Lab Site 1004 - Guangzhou

California

  • Zai Lab Site 2001 - San Francisco

New York

  • Zai Lab Site 2002 - New York

Ohio

  • Zai Lab Site 2024 - Cleveland

Pennsylvania

  • Zai Lab Site 2004 - Philadelphia

Virginia

  • Zai Lab Site 2006 - Fairfax

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2025-05-12
Est. Completion 2027-12
Phase Phase 1

Sponsor

Zai Lab (Shanghai) Co.

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06885281

The ClinicalTrials.gov registry entry for NCT06885281 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 284-participant average among 125 other Solid Tumors trials with a reported enrollment target (61% lower). The listed sponsor is Zai Lab (Shanghai) Co., which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumors appearing as the primary indexed condition, and to 1 intervention - of which ZL-1310 is the first listed.

NCT06885281 reports 16 study locations spanning 13 distinct geographic areas - top geographies include Texas, Beijing Municipality, Guangdong.

Frequently Asked Questions

What is clinical trial NCT06885281 about?

NCT06885281 is a clinical study titled "A Study of ZL-1310 in Participants With Selected Solid Tumors". A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

What is the current status of trial NCT06885281?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 112 participants. The study started on 2025-05-12. Estimated completion is 2027-12.

What conditions does trial NCT06885281 study?

This clinical trial studies the following conditions: Solid Tumors.

What interventions are being tested in trial NCT06885281?

The interventions under investigation include: ZL-1310 (DRUG).

Who is sponsoring clinical trial NCT06885281?

This trial is sponsored by Zai Lab (Shanghai) Co., which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06885281 being conducted?

This trial has 16 study locations across California, New York, Ohio, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumors

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.